Last edition
News about "Biomarker Qualification Programme (BQP)"
FDA Qualifies PathAI's AIM-MASH as First AI Tool for MASH Clinical Trials
PathAI has achieved a regulatory milestone with the FDA qualifying its AIM-MASH AI Assist as the first AI-powered tool for MASH clinical trials. The qualification follows the EMA CHMP’s endorsement earlier this year, reinforcing PathAI’s leadership in advancing AI-driven histopathology solutions across American and European drug-development framework.
Biomarker Qualification Programme (BQP) | 10/12/2025 | By Akanki | 1077
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy